Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317508629> ?p ?o ?g. }
- W4317508629 endingPage "1981" @default.
- W4317508629 startingPage "1981" @default.
- W4317508629 abstract "Following the glutamatergic theory of schizophrenia and based on our previous study regarding the antipsychotic-like activity of mGlu7 NAMs, we synthesized a new compound library containing 103 members, which were examined for NAM mGlu7 activity in the T-REx 293 cell line expressing a recombinant human mGlu7 receptor. Out of the twenty-two scaffolds examined, active compounds were found only within the quinazolinone chemotype. 2-(2-Chlorophenyl)-6-(2,3-dimethoxyphenyl)-3-methylquinazolin-4(3H)-one (A9-7, ALX-171, mGlu7 IC50 = 6.14 µM) was selective over other group III mGlu receptors (mGlu4 and mGlu8), exhibited satisfactory drug-like properties in preliminary DMPK profiling, and was further tested in animal models of antipsychotic-like activity, assessing the positive, negative, and cognitive symptoms. ALX-171 reversed DOI-induced head twitches and MK-801-induced disruptions of social interactions or cognition in the novel object recognition test and spatial delayed alternation test. On the other hand, the efficacy of the compound was not observed in the MK-801-induced hyperactivity test or prepulse inhibition. In summary, the observed antipsychotic activity profile of ALX-171 justifies the further development of the group of quinazolin-4-one derivatives in the search for a new drug candidate for schizophrenia treatment." @default.
- W4317508629 created "2023-01-20" @default.
- W4317508629 creator A5002292474 @default.
- W4317508629 creator A5006523340 @default.
- W4317508629 creator A5007893155 @default.
- W4317508629 creator A5008781693 @default.
- W4317508629 creator A5018290151 @default.
- W4317508629 creator A5024524655 @default.
- W4317508629 creator A5025399512 @default.
- W4317508629 creator A5029451001 @default.
- W4317508629 creator A5033794839 @default.
- W4317508629 creator A5034173810 @default.
- W4317508629 creator A5034604911 @default.
- W4317508629 creator A5040355648 @default.
- W4317508629 creator A5050310888 @default.
- W4317508629 creator A5051500213 @default.
- W4317508629 creator A5063121300 @default.
- W4317508629 creator A5064915633 @default.
- W4317508629 creator A5082517862 @default.
- W4317508629 creator A5090499212 @default.
- W4317508629 date "2023-01-19" @default.
- W4317508629 modified "2023-10-17" @default.
- W4317508629 title "Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties" @default.
- W4317508629 cites W1853259224 @default.
- W4317508629 cites W1914381346 @default.
- W4317508629 cites W1965649191 @default.
- W4317508629 cites W1974352942 @default.
- W4317508629 cites W1976564830 @default.
- W4317508629 cites W1980102165 @default.
- W4317508629 cites W1981718198 @default.
- W4317508629 cites W1983341853 @default.
- W4317508629 cites W1993409548 @default.
- W4317508629 cites W1994864252 @default.
- W4317508629 cites W2004531151 @default.
- W4317508629 cites W2008960811 @default.
- W4317508629 cites W2014376853 @default.
- W4317508629 cites W2016413308 @default.
- W4317508629 cites W2023343746 @default.
- W4317508629 cites W2024395643 @default.
- W4317508629 cites W2027277650 @default.
- W4317508629 cites W2028531603 @default.
- W4317508629 cites W2030967437 @default.
- W4317508629 cites W2036768479 @default.
- W4317508629 cites W2037829509 @default.
- W4317508629 cites W2052190109 @default.
- W4317508629 cites W2054390599 @default.
- W4317508629 cites W2056095008 @default.
- W4317508629 cites W2061934797 @default.
- W4317508629 cites W2063334178 @default.
- W4317508629 cites W2064865856 @default.
- W4317508629 cites W2065940220 @default.
- W4317508629 cites W2067166581 @default.
- W4317508629 cites W2067294686 @default.
- W4317508629 cites W2069155296 @default.
- W4317508629 cites W2079396676 @default.
- W4317508629 cites W2085526888 @default.
- W4317508629 cites W2086494679 @default.
- W4317508629 cites W2093890599 @default.
- W4317508629 cites W2110960534 @default.
- W4317508629 cites W2114879872 @default.
- W4317508629 cites W2115142999 @default.
- W4317508629 cites W2120307371 @default.
- W4317508629 cites W2130445124 @default.
- W4317508629 cites W2131350133 @default.
- W4317508629 cites W2135370934 @default.
- W4317508629 cites W2150669269 @default.
- W4317508629 cites W2153401842 @default.
- W4317508629 cites W2153795172 @default.
- W4317508629 cites W2158137297 @default.
- W4317508629 cites W2161891468 @default.
- W4317508629 cites W2328696343 @default.
- W4317508629 cites W2435831229 @default.
- W4317508629 cites W2488841347 @default.
- W4317508629 cites W2746689298 @default.
- W4317508629 cites W2753582459 @default.
- W4317508629 cites W2767659547 @default.
- W4317508629 cites W2781931666 @default.
- W4317508629 cites W2888398116 @default.
- W4317508629 cites W2891793401 @default.
- W4317508629 cites W2895652264 @default.
- W4317508629 cites W2895819009 @default.
- W4317508629 cites W2908348801 @default.
- W4317508629 cites W2921469433 @default.
- W4317508629 cites W2991188715 @default.
- W4317508629 cites W3043535160 @default.
- W4317508629 cites W3080143032 @default.
- W4317508629 cites W3104125575 @default.
- W4317508629 cites W794213711 @default.
- W4317508629 doi "https://doi.org/10.3390/ijms24031981" @default.
- W4317508629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36768302" @default.
- W4317508629 hasPublicationYear "2023" @default.
- W4317508629 type Work @default.
- W4317508629 citedByCount "3" @default.
- W4317508629 countsByYear W43175086292023 @default.
- W4317508629 crossrefType "journal-article" @default.
- W4317508629 hasAuthorship W4317508629A5002292474 @default.
- W4317508629 hasAuthorship W4317508629A5006523340 @default.
- W4317508629 hasAuthorship W4317508629A5007893155 @default.